Co-Authors
This is a "connection" page, showing publications co-authored by FREDRICK B HAGEMEISTER and CAMILO JIMENEZ.
Connection Strength
0.109
-
Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial. Clin Lymphoma Myeloma Leuk. 2013 Apr; 13(2):99-105.
Score: 0.109
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.